# LLM Judge Evaluation: tier3_001

## Overall: PASS

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 2/2
- **Total**: 4/6

### Reasoning:
Completion: The agent executed a full workflow (lookup → tautomer search → pKa for tautomers → descriptors → interpretation) and retrieved final numbers, then reasoned to the dominant species and protein binding. So completion is strong.

Correctness: Key property pKa is the load-bearing parameter for speciation. Literature places warfarin’s acidic pKa near 4.9–5.0, whereas the agent reported 2.64 (off by ~2.3 pH units, >30%). That materially affects quantitative speciation (though the qualitative conclusion—anion at pH 7.4—still holds). The reported logP (2.98) is within ~0.3 of experimental values (≈2.7), so that part is acceptable. Protein binding was described qualitatively and is consistent with literature (≈98–99.5% bound), but some residue-level interaction claims (e.g., Lys199, Phe223) were not rigorously supported; canonical Site I contacts include Trp214, Arg218, Arg222, His242, Arg257. Overall, because pKa is far off, correctness is penalized.

Tool use: The sequence and tool choices were appropriate and logically ordered; status checks and retrievals succeeded. However, the very low pKa suggests the chosen rapid method and/or ionization microstate coverage may have been inadequate (e.g., solvent model, conformer/tautomer sampling, calibration). Still, tool use itself was correct and successful.

Net: Completed well, but with a critical numerical inaccuracy on pKa; docking/site claims could use primary structural citation support.

### Feedback:
- The pKa is substantially underestimated. Consider: (a) enumerating all relevant microstates and tautomers with Boltzmann weighting; (b) using a higher-level solvation model or explicit-solvent thermodynamic cycle; (c) calibrating against reference acids (e.g., 4-hydroxycoumarin) to correct method bias.
- Support residue-level binding claims with primary structures (PDB 1HA2/1H9Z/2BXD) and report actual contacting residues; avoid speculative Lys199/Phe223 assertions unless directly evidenced.
- If reporting descriptors (TPSA, Fukui indices), include the exact tool outputs and versions; current TPSA appears inconsistent with widely reported values.
- Nice job completing the workflow and clearly identifying the dominant anionic species at physiological pH; keep the strong structure in future runs but tighten numerical validation against literature.
- Literature validation: Property: pKa (acidic)
- Agent value: 2.64
- Literature value: 4.94 (stated in study abstract) `https://pubmed.ncbi.nlm.nih.gov/28093289/` ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai)); also DrugBank experimental pKa 5.0 `https://go.drugbank.com/drugs/DB00682` ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682?utm_source=openai))
- Absolute error (vs 4.94): 2.30
- Percent error: 46.6%
- Score justification: >1.5 pH units off (>30% error) → fails pKa accuracy criterion.

Property: logP
- Agent value: 2.98
- Literature value: 2.70 (experimental, Hansch et al.) `https://go.drugbank.com/drugs/DB00682` ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682?utm_source=openai))
- Absolute error: 0.28
- Percent error: 10.4%
- Score justification: within ±0.3 → meets logP accuracy criterion.

Context checks (not scored but relevant):
- Protein binding: Literature shows free fraction 0.004–0.019 (98.1–99.6% bound) `https://pubmed.ncbi.nlm.nih.gov/1277711/` and `https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt1976195part1552` ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/1277711/?utm_source=openai)).
- Binding site/residues: Warfarin binds HSA Sudlow Site I; structural data and curated residue contacts (Trp214, Arg218, Arg222, His242, Arg257, etc.) `https://www.rcsb.org/structure/1HA2` `https://www.rcsb.org/structure/1h9z` `https://www.rcsb.org/structure/2bxd` and binding-site detail `https://idrblab.net/ttd/data/target-ligand-binding-site/details/T63068-Ligand%3ARWF` ([www1.rcsb.org](https://www1.rcsb.org/structure/1HA2?utm_source=openai)); His242 protonation effect consistent with `https://pubmed.ncbi.nlm.nih.gov/16563025/` ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/16563025/?utm_source=openai)).
- Dominant species at pH 7.4: With pKa ≈ 4.9–5.0, warfarin is predominantly anionic at pH 7.4 (qualitative conclusion matches literature statements) `https://pubmed.ncbi.nlm.nih.gov/28093289/` ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai)).

### Web Search Citations:
1. [R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies - PubMed](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai)
2. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682?utm_source=openai)
3. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682?utm_source=openai)
4. [Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect - PubMed](https://pubmed.ncbi.nlm.nih.gov/1277711/?utm_source=openai)
5. [RCSB PDB - 1HA2: Human Serum Albumin Complexed With Myristic Acid and the S-(-) enantiomer of warfarin](https://www1.rcsb.org/structure/1HA2?utm_source=openai)
6. [Binding of warfarin influences the acid-base equilibrium of H242 in sudlow site I of human serum albumin - PubMed](https://pubmed.ncbi.nlm.nih.gov/16563025/?utm_source=openai)
7. [R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies - PubMed](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai)

### Execution:
- **Tools**: workflow_get_status, retrieve_workflow, molecule_lookup, submit_tautomer_search_workflow, submit_descriptors_workflow, submit_pka_workflow, retrieve_calculation_molecules
- **Time**: 21.3 min

---
*Evaluated with openai/gpt-5*
